Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

239
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
239
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

153
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
153
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

315
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
315
Randomized Experiments01:13

Randomized Experiments

7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.1K
Study Design in Statistics01:15

Study Design in Statistics

8.3K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.3K
Crossover Experiments01:16

Crossover Experiments

2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease risk perception, health intervention intention and their influencing factors among prehypertensive and hypertensive populations: a cross-sectional study with 1050 participants.

BMC public health·2026
Same author

Relation between Time from Onset to Randomization and Benefit Magnitude in Recent Clinical Trials of Thrombectomy for Patients with Large Ischemic Cores.

Annals of Indian Academy of Neurology·2026
Same author

Optimizing rare neurological disease trials: Bayesian frameworks and hierarchical models for improved efficiency in clinical trial design.

Journal of biopharmaceutical statistics·2026
Same author

Prediction and monitoring of accrual and rate of underrepresented biomedical research group using bayesian methods.

BMC medical research methodology·2026
Same author

Unblinded by the Night: Predictive Power for Complex Bayesian Adaptive Trials When Sight Privileges Vary.

Pharmaceutical statistics·2026
Same author

Estimating Baseline Cutoffs for DHA Dosage in Preterm Birth Prevention: A Bayesian Personalized Change-Point Analysis.

Journal of applied statistics·2026

Related Experiment Video

Updated: Aug 8, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Comparative Effectiveness Research using Bayesian Adaptive Designs for Rare Diseases: Response Adaptive Randomization

Fengming Tang1,2, Byron J Gajewski1

  • 1Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, 66160.

Statistics in Biopharmaceutical Research
|March 6, 2023
PubMed
Summary

This study introduces a novel clinical trial design for rare diseases, allowing participants to switch treatments. This response adaptive randomization (RAR) design enhances efficiency, achieving comparable power with smaller sample sizes and shorter durations.

Keywords:
Bayesian Adaptive ModelComparative Effectiveness Researchhierarchical modelsresponse adaptive randomization

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

636

Related Experiment Videos

Last Updated: Aug 8, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

636

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Rare Diseases

Background:

  • Slow patient accrual is a primary cause of clinical trial failure, particularly in rare disease research.
  • Comparative effectiveness research faces amplified challenges due to the need to compare multiple treatments efficiently.
  • There is a critical need for innovative and efficient clinical trial designs to address these limitations.

Purpose of the Study:

  • To propose and evaluate a novel response adaptive randomization (RAR) design that reuses participants.
  • To enhance clinical trial efficiency by allowing treatment switching and adaptive allocation.
  • To improve statistical power and reduce sample size and trial duration, especially for rare diseases.

Main Methods:

  • Developed a participant-reusing response adaptive randomization (RAR) trial design.
  • Simulated the proposed design against traditional single-treatment-per-participant trials.
  • Evaluated efficiency gains in terms of statistical power, sample size, and trial duration under varying accrual rates.

Main Results:

  • The proposed participant-reusing RAR design achieved comparable statistical power to traditional designs.
  • The new design demonstrated significant reductions in sample size and trial duration, particularly with low patient accrual rates.
  • Efficiency gains diminished as the patient accrual rate increased.

Conclusions:

  • Participant-reusing RAR designs offer a more efficient approach for clinical trials in rare diseases and comparative effectiveness research.
  • This innovative design can lead to more ethical and cost-effective studies by optimizing resource allocation.
  • The proposed method effectively addresses the challenge of slow accrual rates, a common barrier in rare disease trials.